Skip to main content
. 2016 Nov 15;155(2):485–496. doi: 10.1093/toxsci/kfw229

FIG. 8.

FIG. 8

Shared targets of human skeletal anomalies associated with heterozygous/LOF mutations and downregulation of orthologous genes in 0.3 nM TCDD-treated medaka.